Jbf Capital, Inc. Sc Pharmaceuticals Inc. Transaction History
Jbf Capital, Inc.
- $684 Million
- Q3 2025
A detailed history of Jbf Capital, Inc. transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Jbf Capital, Inc. holds 135,000 shares of SCPH stock, worth $765,450. This represents 0.11% of its overall portfolio holdings.
Number of Shares
135,000
Previous 765,450
82.36%
Holding current value
$765,450
Previous $4.33 Million
82.36%
% of portfolio
0.11%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding SCPH
# of Institutions
116Shares Held
40.4MCall Options Held
835KPut Options Held
11.9K-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million1.17% of portfolio
-
Rubric Capital Management LP New York, NY5.1MShares$28.9 Million0.47% of portfolio
-
Weiss Asset Management LP Boston, MA2.88MShares$16.3 Million0.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$12.3 Million0.0% of portfolio
-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct2.15MShares$12.2 Million0.01% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...